Longitudinal tumor ecosystem mapping defines glioblastoma treatment trajectories

Consideration of spatial companion biomarkers for targeted therapeutics in cancer: depatuxizumab mafodotin in glioblastoma

STING activation induces cytotoxic and immune responses in meningiomas via inflammatory cell death pathways

Meningioma cell reprogramming and microenvironment interactions underlie brain invasion

Multiomics Image Analysis-Driven Insights into Tumor Microenvironment

Multiomics Image Analysis-Driven Insights into Tumor Microenvironment

Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures

Screening for Tumor Microtube-Targeting Drugs Identifies PKC Modulators as Multipotent Inhibitors of Glioblastoma Progression

Bi-specific T cell-engaging antibody triggers protective immune memory and glioma microenvironment remodeling in immune-competent preclinical models

Integrated immune profiling of chordomas reveals spatially organized niches and functional heterogeneity

Treatment Resistant Persister Cells Exploit Macrophage Lipid Metabolism to Sustain Glioblastoma Growth